209 related articles for article (PubMed ID: 12041744)
1. Influence of teicoplanin on the chemiluminescence of phagocytosing human granulocytes.
Aquilini D; Bartoloni A; Paradisi F
J Chemother; 1991 Jan; 3 Suppl 1():119-21. PubMed ID: 12041744
[TBL] [Abstract][Full Text] [Related]
2. Effect of enoxacin, norfloxacin and pefloxacin on polymorphonuclear leukocytes chemiluminescence.
Aquilini D; Bartoloni A; Paradisi F
J Chemother; 1991 Jan; 3 Suppl 1():116-8. PubMed ID: 12041743
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of phagocytosis against Staphylococcus aureus by teicoplanin and vancomycin.
Pedrera MI; Pérez F; Rodríguez AB; Barriga C
Rev Esp Fisiol; 1993 Dec; 49(4):231-4. PubMed ID: 8209099
[TBL] [Abstract][Full Text] [Related]
4. Microbiological profile of teicoplanin.
Covelli I; Nani E
J Chemother; 1991 Jan; 3 Suppl 1():39-42. PubMed ID: 12041783
[TBL] [Abstract][Full Text] [Related]
5. Teicoplanin and its influence on Staphylococcus aureus ultrastructure.
Tullio V; Cuffini AM; Carlone NA
J Chemother; 1991 Jan; 3 Suppl 1():89-92. PubMed ID: 12041797
[TBL] [Abstract][Full Text] [Related]
6. In-vitro effects of teicoplanin, teicoplanin derivative MDL 62211 and vancomycin on human polymorphonuclear cell function.
Capodicasa E; Scaringi L; Rosati E; De Bellis F; Sbaraglia G; Marconi P; Del Favero A
J Antimicrob Chemother; 1991 May; 27(5):619-26. PubMed ID: 1832144
[TBL] [Abstract][Full Text] [Related]
7. Serial studies of leukocyte chemiluminescence: lack of effect of macrolide antibiotic therapy.
Martin RR; Putman M; Greenberg SB; Wallace RJ; Wilson SZ
J Med; 1980; 11(1):39-48. PubMed ID: 6995547
[TBL] [Abstract][Full Text] [Related]
8. Intracellular activity of both teicoplanin and vancomycin against Staphylococcus aureus in human neutrophils.
Pedrera MI; Barriga C; Rodriguez AB
Comp Immunol Microbiol Infect Dis; 1995 Feb; 18(2):123-8. PubMed ID: 7621668
[TBL] [Abstract][Full Text] [Related]
9. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
Streit JM; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
[TBL] [Abstract][Full Text] [Related]
10. Effect of a new fluorinated quinolone (ofloxacin) on the chemiluminescence of phagocytosing human neutrophils.
Aquilini D; Bartoloni A; Paradisi F
J Biolumin Chemilumin; 1989; 3(2):85-7. PubMed ID: 2728916
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
12. Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):177-84. PubMed ID: 19249179
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial and antioxidant activities in Sideritis italica (Miller) Greuter et Burdet essential oils.
Basile A; Senatore F; Gargano R; Sorbo S; Del Pezzo M; Lavitola A; Ritieni A; Bruno M; Spatuzzi D; Rigano D; Vuotto ML
J Ethnopharmacol; 2006 Sep; 107(2):240-8. PubMed ID: 16690235
[TBL] [Abstract][Full Text] [Related]
14. An assessment of the interaction between human neutrophils, hydroxyapatite and dichloromethylene bisphosphonate in vitro: an electron microscopic and chemiluminescence study.
Hyvönen PM; Kowolik MJ
J Clin Lab Immunol; 1991 Jun; 35(2):47-55. PubMed ID: 1668758
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S
Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
[TBL] [Abstract][Full Text] [Related]
16. In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide.
Lopez S; Hackbarth C; Romanò G; Trias J; Jabes D; Goldstein BP
J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii21-4. PubMed ID: 15750033
[TBL] [Abstract][Full Text] [Related]
17. [Neutrophil chemiluminescence in active cytomegalovirus infection].
Suleĭmanova NS; Skurnik AR; Donnikov AE; Sukhikh GT
Biull Eksp Biol Med; 1993 Jun; 115(6):637-8. PubMed ID: 8397018
[TBL] [Abstract][Full Text] [Related]
18. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic characteristics and antimicrobial spectrum of teicoplanin].
Paganini H; Marin M
Medicina (B Aires); 2002; 62 Suppl 2():52-5. PubMed ID: 12481490
[TBL] [Abstract][Full Text] [Related]
20. A study of the possible interactions between human platelets and the antibiotic MDL-507 (teicoplanin).
Porta M; Ricchetti I
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):661-4. PubMed ID: 2950065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
